The US healthcare system under Trump 2.0 are likely to benefit Indian players, except for the push for increased US drug ...

Jan. 15, 2025 — Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. ... New Innovative Local Treatment ...

The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...

The Indian pharma industry is at a juncture where digital transformation is sweeping the healthcare landscape.

Indian equity markets closed lower past week, with the NIFTY down by 573 points or 2.39% and the Sensex down by 2.33%. But ...

Global pharma major Lupin Limited on Thursday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug ...

Mumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur ...

Nilesh Gupta, MD, Lupin said, We are pleased to receive the EIR from the US FDA for our Pithampur Unit-1 facility with a satisfactory ... Mumbai-based Lupin is an innovation-led transnational ...

Lupin: Pharmaceutical company Lupin received an Establishment Inspection Report (EIR) from the US FDA for its Pithampur Unit-1 facility, which manufactures APIs and finished products. The EIR, ...

Global pharma major Lupin Limited (Lupin) announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (FDA) for its Pithampur Unit-1 ...